Free Trial
NASDAQ:BNBX

Applied Dna Sciences (BNBX) Stock Price, News & Analysis

Applied Dna Sciences logo
$0.09 0.00 (0.00%)
As of 11/13/2026 11:30 AM Eastern

About Applied Dna Sciences Stock (NASDAQ:BNBX)

Advanced

Key Stats

Today's Range
$0.08
▼
$0.09
50-Day Range
$0.08
▼
$0.16
52-Week Range
$0.07
▼
$3.36
Volume
2,323 shs
Average Volume
349,891 shs
Market Capitalization
$557.73 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Applied DNA Sciences, Inc. is a biotechnology company that develops DNA-based technologies for molecular diagnostics, therapeutics and industrial applications. Its platform is designed to produce and analyze DNA for use in areas including infectious disease testing, genetic medicine and product authentication.

The company has also developed DNA-based supply-chain and anti-counterfeiting solutions, including technologies intended to help authenticate textiles, pharmaceutical products and other goods. Applied DNA Sciences has served commercial, healthcare and government-related customers, primarily in the United States, while pursuing additional international applications for its technologies.

Applied DNA Sciences is generally identified by the Nasdaq ticker APDN; the ticker BNBX does not appear to correspond to the company. The company was founded in 2003 and has historically been led by Chief Executive Officer James A. Hayward.

AI Generated. May Contain Errors.

Receive BNBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied Dna Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BNBX Stock News Headlines

I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
See More Headlines

BNBX Stock Analysis - Frequently Asked Questions

Applied Dna Sciences' stock was trading at $1.51 on January 27, 2026. Since then, BNBX stock has decreased by 94.0% and is now trading at $0.09.

Applied Dna Sciences Inc (NASDAQ:BNBX) released its earnings results on Friday, May, 15th. The company reported ($0.68) earnings per share for the quarter. The company had revenue of $1.02 million for the quarter. Applied Dna Sciences had a negative trailing twelve-month return on equity of 349.95% and a negative net margin of 1,647.25%.

Shares of BNBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/13/2026
Today
11/15/2026
Fiscal Year End
9/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:BNBX
CIK
744452
Employees
70
Year Founded
1983

Profitability

EPS (Trailing Twelve Months)
($3.33)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.16 million
Net Margins
-1,647.25%
Pretax Margin
-1,671.00%
Return on Equity
-349.95%
Return on Assets
-283.96%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.82
Quick Ratio
1.74

Sales & Book Value

Annual Sales
$2.09 million
Price / Sales
0.27
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.50 per share
Price / Book
0.06

Miscellaneous

Outstanding Shares
6,197,000
Free Float
6,755,000
Market Cap
$557.73 thousand
Optionable
N/A
Beta
0.67

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:BNBX) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners